Latest & greatest articles for amphetamine

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on amphetamine or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on amphetamine and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for amphetamine

1. Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders

Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders Cognitive‐behavioural treatment for amphetamine‐type stimulants (ATS)‐use disorders - Harada - 2019 - Campbell Systematic Reviews - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term SYSTEMATIC REVIEW Open Access Cognitive‐behavioural treatment for amphetamine‐type stimulants (ATS)‐use disorders Department (...) globally and it is now the second most popular illicit drug in the world after cannabis. ATS use is of serious concern in East Asia, Southeast Asia, North America, Western Europe and Oceania (Farrell, Marsden, Ali, & Ling, ; UNODC, ). Statistics from the United Nations Office on Drugs and Crime (UNODC) indicate that approximately 25 million to 80 million people regularly use ATS worldwide (UNODC, ). Several new synthetic drugs have been gaining popularity, including MDMA and related amphetamines

Full Text available with Trip Pro

2019 Campbell Collaboration

2. Psychosis with Methylphenidate or Amphetamine in Patients with ADHD. (PubMed)

Psychosis with Methylphenidate or Amphetamine in Patients with ADHD. The prescription use of the stimulants methylphenidate and amphetamine for the treatment of attention deficit-hyperactivity disorder (ADHD) has been increasing. In 2007, the Food and Drug Administration mandated changes to drug labels for stimulants on the basis of findings of new-onset psychosis. Whether the risk of psychosis in adolescents and young adults with ADHD differs among various stimulants has not been extensively (...) studied.We used data from two commercial insurance claims databases to assess patients 13 to 25 years of age who had received a diagnosis of ADHD and who started taking methylphenidate or amphetamine between January 1, 2004, and September 30, 2015. The outcome was a new diagnosis of psychosis for which an antipsychotic medication was prescribed during the first 60 days after the date of the onset of psychosis. To estimate hazard ratios for psychosis, we used propensity scores to match patients who

2019 NEJM

3. Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis

Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis Clinical guidelines recommend psychosocial interventions for cocaine and/or amphetamine addiction as first-line treatment, but it is still unclear which intervention, if any, should be offered first. We aimed to estimate the comparative effectiveness of all available psychosocial interventions (alone or in combination (...) ) for the short- and long-term treatment of people with cocaine and/or amphetamine addiction.We searched published and unpublished randomised controlled trials (RCTs) comparing any structured psychosocial intervention against an active control or treatment as usual (TAU) for the treatment of cocaine and/or amphetamine addiction in adults. Primary outcome measures were efficacy (proportion of patients in abstinence, assessed by urinalysis) and acceptability (proportion of patients who dropped out due to any

Full Text available with Trip Pro

2019 EvidenceUpdates

4. Amphetamines probably the best first-choice treatment for adults with ADHD

Amphetamines probably the best first-choice treatment for adults with ADHD Amphetamines probably the best first-choice treatment for adults with ADHD Discover Portal Discover Portal Amphetamines probably the best first-choice treatment for adults with ADHD Published on 30 October 2018 doi: There is further evidence to support the amphetamines as the most effective group of drugs for treating adults with attention deficit hyperactivity disorder in the short-term. Two of these drugs were shown (...) to provide the most improvement in core symptoms of attention deficit hyperactivity disorder, are tolerated as well as any other drug treatment and are less likely to be stopped. The review did not identify data to determine whether amphetamines should continue to be used for longer than 12 weeks. This large, comprehensive NIHR-funded systematic review included published and unpublished randomised controlled trials of different drug treatments. The quality of the included trials was mixed, with only

2019 NIHR Dissemination Centre

5. Methamphetamine, amphetamine and aggression in humans: a systematic review and meta-analysis of drug administration studies

Methamphetamine, amphetamine and aggression in humans: a systematic review and meta-analysis of drug administration studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

6. Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders. (PubMed)

Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders. Amphetamine-type stimulants (ATS) refer to a group of synthetic stimulants including amphetamine, methamphetamine, 3,4-methylenedioxy-methamphetamine (MDMA) and related substances. ATS are highly addictive and prolonged use may result in a series of mental and physical symptoms including anxiety, confusion, insomnia, mood disturbances, cognitive impairments, paranoia, hallucinations and delusion.Currently

Full Text available with Trip Pro

2018 Cochrane

7. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. (PubMed)

Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. Attention deficit hyperactivity disorder (ADHD) is a childhood-onset disorder characterised by inattention, hyperactivity, and impulsivity. ADHD can persist into adulthood and can affects individuals' social and occupational functioning, as well as their quality of life and health. ADHD is frequently associated with other mental disorders such as substance use disorders and anxiety and affective disorders. Amphetamines (...) are used to treat adults with ADHD, but uncertainties about their efficacy and safety remain.To examine the efficacy and safety of amphetamines for adults with ADHD.In August 2017, we searched CENTRAL, MEDLINE, Embase, PsycINFO, 10 other databases, and two trials registers, and we ran citation searches for included studies. We also contacted the corresponding authors of all included studies, other experts in the field, and the pharmaceutical company, Shire, and we searched the reference lists

Full Text available with Trip Pro

2018 Cochrane

8. Amphetamine

Amphetamine Top results for amphetamine - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2 (...) ) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for amphetamine The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms

2018 Trip Latest and Greatest

9. Naltrexone in amphetamine-type stimulant use disorders: a systematic review

Naltrexone in amphetamine-type stimulant use disorders: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect

2018 PROSPERO

10. Systematic review of mortality among people who use opioids, cocaine, or amphetamine-type stimulants

Systematic review of mortality among people who use opioids, cocaine, or amphetamine-type stimulants Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2018 PROSPERO

11. Prevalence of amphetamine and methamphetamine use in general population in Iran

Prevalence of amphetamine and methamphetamine use in general population in Iran Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2018 PROSPERO

13. The Use of Amphetamines for Improving Cognitive Impairment in Patients with Multiple Sclerosis

The Use of Amphetamines for Improving Cognitive Impairment in Patients with Multiple Sclerosis "The Use of Amphetamines for Improving Cognitive Impairment in Patients" by Hayley Kum < > > > > > Title Author Date of Graduation Summer 8-13-2016 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies First Advisor Elizabeth Crawford, PA-C, MS Second Advisor Annjanette Sommers, PA-C, MS Rights . Abstract Background: Multiple sclerosis (MS) is an autoimmune disorder (...) that results in debilitating cognitive impairment in 40-65% of patients. There are no current treatments for this symptom of MS. This is a systematic review of literature on the impact amphetamines have on cognitive function of MS patients. Methods: An exhaustive search of available medical literature was conducted using MEDLINE-Ovid, MEDLINE-PubMed, Web of Science, and CINAHL. Keywords used included: amphetamines and multiple sclerosis. Relevant articles were assessed for quality using GRADE. Results

2016 Pacific University EBM Capstone Project

14. Which individual, social and environmental influences shape different pathways of amphetamine type stimulant use over the life course? A systematic review and thematic synthesis of the qualitative literature

Which individual, social and environmental influences shape different pathways of amphetamine type stimulant use over the life course? A systematic review and thematic synthesis of the qualitative literature Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files

2016 PROSPERO

15. Association of anxiety and amphetamine use: a systematic review

Association of anxiety and amphetamine use: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures

2016 PROSPERO

16. Cognitive-behavioural treatment for amphetamine-type stimulants (ATS) use disorders [Cochrane Protocol]

Cognitive-behavioural treatment for amphetamine-type stimulants (ATS) use disorders [Cochrane Protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2015 PROSPERO

17. Pharmacologic treatment of toxicity from amphetamine, amphetamine derivatives such as methamphetamine and MDMA, and bath salts: a systematic review

Pharmacologic treatment of toxicity from amphetamine, amphetamine derivatives such as methamphetamine and MDMA, and bath salts: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2015 PROSPERO

18. Emergency Department based Preventive Health Interventions targeting harmful use of amphetamine type stimulants

Emergency Department based Preventive Health Interventions targeting harmful use of amphetamine type stimulants Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2015 PROSPERO

19. No evidence of benefit of psychostimulants for amphetamine abuse or dependence

No evidence of benefit of psychostimulants for amphetamine abuse or dependence No evidence of benefit of psychostimulants for amphetamine abuse or dependence | Cochrane Primary Care Trusted evidence. Informed decisions. Better health. Enter terms No evidence of benefit of psychostimulants for amphetamine abuse or dependence Cochrane Trusted evidence. Informed decisions. Better health. Copyright © 2019 The Cochrane Collaboration | | We use cookies to improve your experience on our site.

2014 Cochrane PEARLS

20. Efficacy of psychostimulant drugs for amphetamine abuse or dependence. (PubMed)

Efficacy of psychostimulant drugs for amphetamine abuse or dependence. Amphetamine dependence is a public health problem with medical, psychiatric, cognitive, legal and socioeconomic consequences. To date, no pharmacological treatment has been approved for this disorder, and psychotherapy remains the mainstay of treatment. In recent years, psychostimulants have been investigated as a possible replacement therapy.To evaluate the efficacy and safety of psychostimulant medications for amphetamine (...) lists of retrieved trials, the list of studies citing the included trials and the main electronic registers of ongoing trials (ClinicalTrials.gov, International Clinical Trials Registry Platform and EU Clinical Trials Register). Finally, we contacted investigators to request information about unpublished trials. Searches included non-English language literature.All randomised, placebo-controlled, parallel-group clinical trials investigating the efficacy or safety of psychostimulants for amphetamine

Full Text available with Trip Pro

2013 Cochrane